BPC
MRNA icon

Banque Pictet & Cie’s Moderna MRNA Stock Holding History

Banque Pictet & Cie’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,351
Closed -$1.23M – 314
2024
Q2 		$1.23M Buy
+10,351
New +$1.31M 0.01% 215

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Banque Pictet & Cie's MRNA Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Moderna (MRNA) stake by 1.8% in Q2 2026, selling an estimated $2.55M and leaving 2,699,402 shares worth $189M. The position accounts for 1.18% of the portfolio, ranked #15.

Banque Pictet & Cie first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.16B in Q3 2021. 259 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Banque Pictet & Cie held 2,699,402 shares of Moderna worth $189M as of Q2 2026.
  • Banque Pictet & Cie sold 49,352 Moderna shares in Q2 2026, an estimated $2.55M.
  • Moderna made up 1.18% of Banque Pictet & Cie's portfolio in Q2 2026, its #15 holding.
  • Banque Pictet & Cie first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
  • Banque Pictet & Cie's Moderna position peaked at $1.16B in Q3 2021.
  • 259 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.